Net Cash Provided by (Used in) Financing Activities of OptiNose, Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
OptiNose, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • OptiNose, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $0.
  • OptiNose, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $55,553,000, a 18418% increase from 2023.
  • OptiNose, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $300,000, a 99% decline from 2022.
  • OptiNose, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $51,436,000, a 19% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

OptiNose, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$7,000 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $7,000* -$155,000 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $162,000 -$87,000 -35% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $249,000 +$320,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $71,000 -$29,449,000 -100% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $29,378,000 +$29,190,000 +15527% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $188,000 +$1,881,000 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $1,693,000 -$36,508,000 -105% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $34,815,000 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

OptiNose, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $55,553,000 +$55,253,000 +18418% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $300,000 -$51,136,000 -99% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $51,436,000 +$8,116,000 +19% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $43,320,000 -$40,490,000 -48% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2023 2022 FY
2020 $83,810,000 +$46,281,000 +123% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY
2019 $37,529,000 -$22,050,000 -37% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2021 2020 FY
2018 $59,579,000 -$176,546,000 -75% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $236,125,000 +$236,070,000 +429218% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 $55,000 -$19,068,000 -100% 01 Jan 2016 31 Dec 2016 10-K 13 Mar 2018 2017 FY
2015 $19,123,000 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.